Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran Cermin Dunia Kedokteran
Frischa
General physician, Jakarta, Indonesia
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Mechanical Ventilation Management in COVID-19 Patients Wibowo; Frischa; Harjanto; Bernadus Realino Realino
Cermin Dunia Kedokteran Vol 49 No 4 (2022): Penyakit Dalam
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i4.226

Abstract

Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), was first reported in Wuhan, Hubei, China, and has spread to more than 200 other countries around the world. COVID-19 can be complicated by severe pneumonia, ARDS, sepsis, and septic shock in severe cases. About 80% of cases are mild or moderate, 13.8% have severe disease, and 6.1% fall into a critical condition. Positive responses in COVID-19 patients with respiratory failure are usually seen right after the initiation of NIV and HFNC. If there is no substantial improvement in gas exchange and respiratory rate within a few hours, invasive mechanical ventilation should be started without delay. Delayed intubation increases COVID-19 ARDS mortality. Coronavirus disease 2019 (COVID-19), yang disebabkan oleh Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), pertama kali dilaporkan di Wuhan, Hubei, China, dan telah menyebar ke lebih dari 200 negara lain di seluruh dunia. Manifestasi klinis pasien COVID-19 sebagian besar tidak bergejala (asimtomatik), namun dapat diperumit dengan pneumonia berat, ARDS, sepsis, hingga syok septik. Sekitar 80% kasus biasanya ringan atau sedang, 13,8% mengalami gejala berat, dan 6,1% pasien mengalami kondisi kritis. Respons positif biasanya terlihat segera setelah dimulainya NIV dan HFNC. Jika tidak ada perbaikan substansial dalam pertukaran gas dan laju pernapasan dalam beberapa jam, ventilasi mekanik invasif harus dimulai segera. Intubasi yang tertunda meningkatkan mortalitas ARDS.
Mechanical Ventilation Management in COVID-19 Patients Wibowo; Frischa; Harjanto; Bernadus Realino Realino
Cermin Dunia Kedokteran Vol 49 No 4 (2022): Penyakit Dalam
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v49i4.226

Abstract

Coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), was first reported in Wuhan, Hubei, China, and has spread to more than 200 other countries around the world. COVID-19 can be complicated by severe pneumonia, ARDS, sepsis, and septic shock in severe cases. About 80% of cases are mild or moderate, 13.8% have severe disease, and 6.1% fall into a critical condition. Positive responses in COVID-19 patients with respiratory failure are usually seen right after the initiation of NIV and HFNC. If there is no substantial improvement in gas exchange and respiratory rate within a few hours, invasive mechanical ventilation should be started without delay. Delayed intubation increases COVID-19 ARDS mortality. Coronavirus disease 2019 (COVID-19), yang disebabkan oleh Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), pertama kali dilaporkan di Wuhan, Hubei, China, dan telah menyebar ke lebih dari 200 negara lain di seluruh dunia. Manifestasi klinis pasien COVID-19 sebagian besar tidak bergejala (asimtomatik), namun dapat diperumit dengan pneumonia berat, ARDS, sepsis, hingga syok septik. Sekitar 80% kasus biasanya ringan atau sedang, 13,8% mengalami gejala berat, dan 6,1% pasien mengalami kondisi kritis. Respons positif biasanya terlihat segera setelah dimulainya NIV dan HFNC. Jika tidak ada perbaikan substansial dalam pertukaran gas dan laju pernapasan dalam beberapa jam, ventilasi mekanik invasif harus dimulai segera. Intubasi yang tertunda meningkatkan mortalitas ARDS.
Co-Authors Bernadus Realino Realino Harjanto Wibowo